Anesthesia and Respiratory Devices Market is estimated to be valued at US$ 27,623.8 Mn in 2019 and is expected to increase to US$ 44,241.2 Mn by 2027.
Respiratory care devices are used for diagnosis and treatment of respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, tuberculosis, and pneumonia. Anesthesia is the administration of medication to allow medical procedures to be done without pain, and in some cases, without the patient being aware during the procedure.
Respiratory care devices are used for diagnosis and treatment of respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, tuberculosis, and pneumonia. These devices provide enhanced care to patients suffering from such acute and chronic respiratory diseases. Since the last decade, increase in prevalence of respiratory diseases is a pivotal factor that drives the respiratory care devices market. Anesthesia devices are used during surgical procedures to control pain, breathing, blood pressure, blood flow, and heart rate & rhythm.
To request a sample copy or view summary of this report, click the Here
Key players in the global Anesthesia and Respiratory Devices market covered: Medtronic,ALung Technologies,AirSep Corporation,Fisher & Paykel Healthcare,Intersurgical,Chart Industries,Philips Healthcare,BOMImed,ResMed,Drager,Masimo Corporation,LMA International NV,Teleflex,GE Healthcare,Getinge Group,Amsino International,CareFusion,BD,ConvaTec,B. Braun Medical Inc.,Consort Medical,Smiths Medical,Acutronic Medical Systems,Penlon
On the basis of types, the Anesthesia and Respiratory Devices market from 2015 to 2025 is primarily split into:
- Respiratory Devices
- Anesthesia Devices
On the basis of applications, the Anesthesia and Respiratory Devices market from 2015 to 2025 covers:
- Hospitals
- Clinics
- Homecare Settings
- Ambulatory Service Centers
- Others
Geographically, the detailed analysis of production, trade of the following countries is covered:
- United States
- Europe
- China
- Japan
- India
When anesthesia is administered to patients with respiratory diseases then special monitoring and care for the patient is necessary, which require advanced anesthesia monitors and devices for patient care. Moreover increasing prevalence of respiratory diseases such as asthma and COPD, are expected to propel the anesthesia and respiratory device market growth over the forecast period. For instance, according to the Forum of International Respiratory Societies, in 2013, around 235 million people suffered from asthma and over 200 million people were affected from chronic obstructive pulmonary disease (COPD), and around 65 million endure mild-to-severe COPD.
About US
Credible Markets has emerged as a dependable source for the market research needs of businesses within a quick time span. We have collaborated with leading publishers of market intelligence and the coverage of our reports reserve spans all the key industry verticals and thousands of micro markets. The massive repository allows our clients to pick from recently published reports from a range of publishers that also provide extensive regional and country-wise analysis. Moreover, pre-booked research reports are among our top offerings.
Contact Us
Credible Markets Analytics
99 Wall Street 2124 New York, NY 10005
Email: sales@crediblemarkets.com
